|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 13th Street, NW |
Address2 | 11th Floor North |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3867-12
|
||||||||
|
6. House ID# 315600000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jesse Kerns |
Date | 7/20/2022 9:21:12 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to drug pricing reform
H.R.5376, Build Back Better Act
S2891 Restoring America Invents Act
S1435 affordable prescriptions for patients act
H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act
H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
Biosimilars reimbursement issues, no specific bill
Supply Chain Issues, no specific bill
Issues related to clinical trial diversity, HR 6584 DEPICT Act, HR5030 DIVERSE Trials Act, HR 7845 and S2706 NIH Clinical Trial Diversity Act of 2022
Issues related to biodefense issues, S3799 PREVENT Pandemics Act
Issues related to cardiovascular disease awareness, S. 3018/ HR 3173 Improving Seniors Timely Access to Care Act, S.464 Safe Step Act and HR8295 Labor/HHS Appropriations bill
H.R. 5801 HELP Copays Act
Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters
FDA Issues; User Fee Reauthorization HR7667 Food and Drug Amendments Act and S4348 FDA safety and landmark advancement act
H.R. 6963, the Accelerated Approval Integrity Act of 2022
H.R. 7047, a bill to amend Title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes
H.R. 6000, the Cures 2.0 Act
H.R. 7008, the Pre-Approval Information Exchange Act
S4293 Pharmacy benefit managers transparency act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
O'Brien |
|
|
|
Helen |
Rhee |
|
|
|
Jesse |
Kerns |
|
|
|
L. Nicole |
Currie |
|
|
|
Greg |
Portner |
|
|
|
Victoria |
Blatter |
|
|
|
Howard |
Moon |
|
|
|
Ruth |
Hoffman |
|
|
|
Jordan |
Layson |
|
|
|
Kim |
Love |
|
|
|
Winta |
Menghis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to drug pricing reform and Medicare Part D redesign
H.R. 5376 Build Back Better Act
S. 1943 and H.R. 3517, Issues related to DXA scans, osteoporosis
Issues related to the 340B program
issues related to cardiovascular disease awareness
Issues related to ESRD bundle
Issues related to asthma and self-administered drug list
S. 2428 False Claims Amendments Act of 2021
Reimbursement for biologics/biosimilars
Issues related to discarded drugs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
L. Nicole |
Currie |
|
|
|
Greg |
Portner |
|
|
|
Helen |
Rhee |
|
|
|
Jesse |
Kerns |
|
|
|
Victoria |
Blatter |
|
|
|
William |
O'Brien |
|
|
|
Howard |
Moon |
|
|
|
Ruth |
Hoffman |
|
|
|
Jordan |
Layson |
|
|
|
Kim |
Love |
|
|
|
Winta |
Menghis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to corporate and international tax, including regarding Public Law 115-97, Tax Cuts and Jobs Act
Issues related to Puerto Rico
Final Rule, Guidance Related to the Foreign Tax Credit and Clarification of Foreign-Derived Intangible Income
Issues related to OECD negotiations on the taxation of global income
H.R. 5376, Build Back Better Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
L. Nicole |
Currie |
|
|
|
Helen |
Rhee |
|
|
|
Jordan |
Layson |
|
|
|
Victoria |
Blatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S.1435 Affordable Prescriptions for Patients Act
H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act
H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
S 2891 Restore the America Invents Act
FTC related issues, no specific bill
Issues related to the Patent Act
Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill
Mergers and acquisitions, no specific bill
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Helen |
Rhee |
|
|
|
Greg |
Portner |
|
|
|
L. Nicole |
Currie |
|
|
|
William |
O'Brien |
|
|
|
Victoria |
Blatter |
|
|
|
Howard |
Moon |
|
|
|
Jesse |
Kerns |
|
|
|
Jordan |
Layson |
|
|
|
Kim |
Love |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |